These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 8466466

  • 41. Re: Two courses of intravesical bacillus Calmette-Guerin for transitional cell carcinoma of the bladder.
    Herr HW.
    J Urol; 1987 Aug; 138(2):409-10. PubMed ID: 3599266
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [Reiter syndrome after intravesical Bacillus Calmette-Guerin (BCG) immunotherapy: a case report].
    Shiba M, Fujii T, Takatera H.
    Hinyokika Kiyo; 2003 Oct; 49(10):599-601. PubMed ID: 14655604
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Epididymo-orchitis following intravesical bacillus Calmette-Guérin therapy.
    Menke JJ, Heins JR.
    Ann Pharmacother; 2000 Apr; 34(4):479-82. PubMed ID: 10772435
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Impact of Adjuvant Intravesical Bacillus Calmette-Guérin Treatment on Patients with High-Grade T1 Bladder Cancer.
    Novotny V, Froehner M, Ollig J, Koch R, Zastrow S, Wirth MP.
    Urol Int; 2016 Apr; 96(2):136-41. PubMed ID: 26789626
    [Abstract] [Full Text] [Related]

  • 50. Bacillus Calmette-Guérin immunotherapy. Techniques and results.
    Brosman SA.
    Urol Clin North Am; 1992 Aug; 19(3):557-64. PubMed ID: 1636239
    [Abstract] [Full Text] [Related]

  • 51. Primary tuberculosis of the penis after intravesical bacillus Calmette-Guerin instillation therapy.
    Yoshida R, Kawasaki H, Miyajima A, Amagai M, Ohyama M.
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):77-8. PubMed ID: 18355193
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy for bladder carcinoma.
    Marans HY, Bekirov HM.
    J Urol; 1987 Jan; 137(1):111-2. PubMed ID: 3795348
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Disseminated Bacillus Calmette-Guérin Infection Detected on FDG PET/CT Following Intravesical Bacillus Calmette-Guérin Therapy.
    Curley M, Bhardwaj H.
    Clin Nucl Med; 2020 Jul; 45(7):e323-e324. PubMed ID: 32433172
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Urinary tuberculosis caused by Mycobacterium bovis BCG variety, following intravesical instillation].
    Cameo MI, Lezcano MA, Gil D, Blas M.
    Enferm Infecc Microbiol Clin; 2010 Feb; 28(2):134-5. PubMed ID: 19695743
    [No Abstract] [Full Text] [Related]

  • 60. Intravesical bacillus Calmette-Guerin for patients with high-risk superficial bladder cancer.
    Klimberg IW, Pow-Sang JM, Cartwright CK, Wajsman Z.
    Urology; 1991 Feb; 37(2):180-4. PubMed ID: 1992591
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.